Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. 1996

B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
Cambridge Antibody Technology Ltd., Melbourn, Cambridgeshire, UK.

Methods for the generation of large numbers of different bispecific antibodies are presented. Cloning strategies are detailed to create repertoires of bispecific diabody molecules with variability on one or both of the antigen binding sites. This diabody format, when combined with the power of phage display technology, allows the generation and analysis of thousands of different bispecific molecules. Selection for binding presumably also selects for more stable diabodies. Phage diabody libraries enable screening or selection of the best combination bispecific molecule with regards to affinity of binding, epitope recognition and pairing before manufacture of the best candidate.

UI MeSH Term Description Entries
D007128 Immunoglobulin Fragments Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques. Antibody Fragment,Antibody Fragments,Ig Fragment,Ig Fragments,Immunoglobulin Fragment,Fragment, Antibody,Fragment, Ig,Fragment, Immunoglobulin,Fragments, Antibody,Fragments, Ig,Fragments, Immunoglobulin
D010081 Oxazolone Immunologic adjuvant and sensitizing agent. 2-Phenyl-4-(ethoxymethylene)oxazol-5-one,4-Ethoxymethylene-2-phenyloxazolone,4 Ethoxymethylene 2 phenyloxazolone
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004076 Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. Lanadigenin
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
September 2016, Biochemical and biophysical research communications,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
February 2002, Journal of molecular biology,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
January 2007, Nature protocols,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
January 2018, Methods in molecular biology (Clifton, N.J.),
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
August 2003, Journal of immunological methods,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
January 1997, Cancer immunology, immunotherapy : CII,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
May 1993, Nucleic acids research,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
January 2020, Methods in molecular biology (Clifton, N.J.),
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
January 2000, Methods in enzymology,
B T McGuinness, and G Walter, and K FitzGerald, and P Schuler, and W Mahoney, and A R Duncan, and H R Hoogenboom
August 2000, Protein engineering,
Copied contents to your clipboard!